Home › Healthcare and Retirement Living › Oceania Healthcare (NZX:OCA)

Oceania’s cash turnaround gathers pace as care margins and resales improve

Healthcare and Retirement Living By Victor Sage 4 min read

Oceania Healthcare has moved Cash Flow from Existing Operations into a NZ$0.4 million inflow, while underlying EBITDA rose 18% to NZ$49.0 million in the six months to 30 September 2026. The turnaround came with stronger resales, higher care occupancy and lower costs, although the company remained loss-making on a statutory basis and withheld its interim dividend.

  • Cash Flow from Existing Operations improves by NZ$7.0 million to a NZ$0.4 million inflow
  • Underlying EBITDA rises 18% to NZ$49.0 million, with annuity earnings up 83%
  • Record first-half resales lift 11% to 200, while resale margin reaches 19.9%
  • Net debt falls to NZ$498.7 million and gearing declines to 29.6%
  • No interim dividend declared despite positive cash flow from operations

Cash flow crosses into positive territory

Oceania Healthcare Limited (NZX:OCA, ASX:OCA) has reached the milestone it set itself for FY27, but only just: Cash Flow from Existing Operations was a NZ$0.4 million inflow for the six months to 30 September 2026, a NZ$7.0 million improvement from the restated NZ$6.6 million outflow a year earlier. Free Cash Flow from Operations, after one-off items, was NZ$1.3 million.

The company said CFEO was also positive in October, taking the year-to-date inflow to NZ$4.3 million. That progress matters because Oceania’s dividend policy targets distributions of 40% to 60% of Free Cash Flow from Operations. The Board nevertheless declared no interim dividend and will reassess distributions at the FY27 result.

Recurring earnings take a larger share

Underlying EBITDA rose 18% to NZ$49.0 million, or 22% on a normalised basis excluding sites divested in FY26. Annuity EBITDA, which excludes development margin, jumped 83% to NZ$34.5 million and now represents about 70% of underlying EBITDA. The comparison is supported by better care margins, village earnings and resale gains, but these are non-GAAP measures and do not represent cash generated during the period.

Care EBITDA increased 33% to NZ$16.0 million, with the margin expanding to 16.4% from 11.6%. Rolling 12-month care occupancy reached 93.1%, while occupancy at 30 September was 94.3%. Oceania attributed the improvement to occupancy initiatives, rostering aligned with resident acuity and higher premium-care revenue. Care Annuity EBITDA per occupied bed rose 48% to NZ$24,400.

Resales offset a weaker new-sales market

Resales provided the clearest operational lift. Settlements increased 11% to a record first-half 200, gross resale value rose 32% to NZ$122.5 million and resale margin improved 2.9 percentage points to 19.9%. Resale gains reached NZ$24.3 million, compared with NZ$15.7 million in the prior corresponding period. The result builds on Oceania’s FY26 earnings and debt cut, when the company reported higher annual EBITDA and lower net debt.

New sales were more subdued: 75 units settled, down from 91, with no new development completions during the half as planned. Even so, new development stock fell 35% from 216 units at 31 March to 141 at 30 September, releasing capital. Oceania has 81 units scheduled for delivery in the second half across Franklin, Bream Bay, Elmwood and Lady Allum.

Debt falls, but the dividend remains conditional

Net debt declined NZ$8.0 million to NZ$498.7 million and gearing eased to 29.6%, below the company’s 30% to 35% target range. Oceania completed a NZ$125 million six-year retail bond in July, using the proceeds to repay bank debt and extend its funding profile. It reported NZ$226 million of funding headroom, a 4.2-times interest cover ratio and a 31.8% loan-to-value ratio.

The balance sheet still has a nearer-term refinancing issue: the NZ$125 million OCA010 bonds mature in October 2027, and the company said refinancing options are being considered. Meanwhile, statutory profit after tax was a NZ$4.4 million loss, while total comprehensive income fell to NZ$5.3 million from NZ$40.4 million, largely because the prior period benefited from materially larger property revaluation gains.

Second-half execution will test the turnaround

Oceania’s immediate targets are demanding but specific: deliver the planned 81 units, reduce remaining unsold and bought-back stock, bank further cost savings towards its roughly NZ$30 million FY27 target and sustain positive CFEO for the full year. The residential property market remains subdued, particularly in Auckland, while proposed Retirement Villages Act changes could alter the timing of resident repayments. Oceania has already adopted a nine-month repayment commitment for new residents, but the final legislative settings remain unsettled.

Bottom Line?

The turnaround is becoming visible in cash, but the next proof point is whether a NZ$0.4 million first-half inflow can survive development deliveries, refinancing and a weak housing market.

Questions in the middle?

  • Can Oceania sustain positive Cash Flow from Existing Operations through the second half and FY27 as development activity increases?
  • Will resale momentum and care margins compensate for slower new sales and the planned delivery of 81 units?
  • How will Oceania refinance the NZ$125 million OCA010 maturity in October 2027 without disrupting its dividend pathway or development plans?

Sources